chr11-4955203-A-C

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PP3_Moderate

The NM_001004748.1(OR51A2):ā€‹c.511T>Gā€‹(p.Cys171Gly) variant causes a missense change. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: not found (cov: 17)
Exomes š‘“: 8.5e-7 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

OR51A2
NM_001004748.1 missense

Scores

4
1
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 5.18
Variant links:
Genes affected
OR51A2 (HGNC:14764): (olfactory receptor family 51 subfamily A member 2) Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. The nomenclature assigned to the olfactory receptor genes and proteins for this organism is independent of other organisms. [provided by RefSeq, Jul 2008]
MMP26 (HGNC:14249): (matrix metallopeptidase 26) Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. The encoded preproprotein is proteolytically processed to generate the mature enzyme. This enzyme may degrade collagen type IV, fibronectin, fibrinogen, and beta-casein, and activate matrix metalloproteinase-9 by cleavage. The protein differs from most MMP family members in that it lacks a conserved C-terminal protein domain. The encoded protein may promote cell invasion in multiple human cancers. [provided by RefSeq, May 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.871

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
OR51A2NM_001004748.1 linkuse as main transcriptc.511T>G p.Cys171Gly missense_variant 1/1 ENST00000380371.1
MMP26NM_021801.5 linkuse as main transcriptc.-144-32865A>C intron_variant ENST00000380390.6
MMP26NM_001384608.1 linkuse as main transcriptc.-152-33067A>C intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
OR51A2ENST00000380371.1 linkuse as main transcriptc.511T>G p.Cys171Gly missense_variant 1/1 NM_001004748.1 P1
MMP26ENST00000380390.6 linkuse as main transcriptc.-144-32865A>C intron_variant 5 NM_021801.5 P1
MMP26ENST00000300762.2 linkuse as main transcriptc.-152-33067A>C intron_variant 1

Frequencies

GnomAD3 genomes
Cov.:
17
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
8.53e-7
AC:
1
AN:
1172008
Hom.:
0
Cov.:
33
AF XY:
0.00
AC XY:
0
AN XY:
587756
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000115
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
17

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsNov 28, 2023The c.511T>G (p.C171G) alteration is located in exon 1 (coding exon 1) of the OR51A2 gene. This alteration results from a T to G substitution at nucleotide position 511, causing the cysteine (C) at amino acid position 171 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.043
T
BayesDel_noAF
Benign
-0.30
CADD
Benign
23
DANN
Benign
0.82
DEOGEN2
Benign
0.0090
T
Eigen
Benign
0.12
Eigen_PC
Benign
-0.22
FATHMM_MKL
Benign
0.34
N
LIST_S2
Benign
0.67
T
M_CAP
Benign
0.034
D
MetaRNN
Pathogenic
0.87
D
MetaSVM
Benign
-0.71
T
MutationAssessor
Pathogenic
4.3
H
MutationTaster
Benign
1.0
N;N
PROVEAN
Pathogenic
-11
D
REVEL
Benign
0.15
Sift
Uncertain
0.0010
D
Sift4G
Pathogenic
0.0010
D
Polyphen
1.0
D
Vest4
0.75
MutPred
0.61
Loss of stability (P = 0.0038);
MVP
0.84
MPC
2.5
ClinPred
1.0
D
GERP RS
1.8
Varity_R
0.78
gMVP
0.39

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr11-4976433; API